A new study published in JAMA Ophthalmology suggests that taking Ozempic or Wegovy may increase the risk of developing a rare form of blindness.
Medical
Novo Nordisk, Eli Lilly Shares Decrease After Roche Reveals Obesity Drug Trial
Shares of pharmaceutical companies Novo Nordisk and Eli Lilly slid after Roche announced results from a promising early-stage trial for its proposed obesity drug.
Smartweave Leads the Way in Personalized Connective Tissue Repair
Smartweave offers a foundationally different approach to connective tissue repair with its intelligent bioscaffold, which focuses on regeneration and rejuvenation rather than mere repair. This innovative solution facilitates tissue regeneration and growth, providing personalized healing tailored to each patient's specific needs, ensuring optimal interaction with the tissue, and promoting effective recovery.
Alzheimer's Treatment Breakthrough: Nasal Sprays Boost Brain Health, Study Suggests
A recent study indicates that nasal sprays containing tiny lipophilic micelles may significantly enhance Alzheimer's treatment by improving cognitive function.
Chinese Report Claims Fuel Trucks Used to Transport Cooking Oil
Chinese authorities are reviewing an investigative report which alleged the practice of using fuel tankers to carry cooking oil, rocking the country into a major food safety scandal.
Latest News
President Joe Biden and Senator Bernie Sanders have urged Novo Nordisk and Eli Lilly to lower the prices of their popular weight loss drugs.
The FDA has approved Eli Lilly’s Alzheimer’s drug donanemab, branded as Kisunla, for early symptomatic adults, providing a new treatment option for nearly 7 million Americans affected by the disease.
The US Food and Drug Administration (FDA) has announced the recall of 135 batches of potassium chloride extended-release capsules due to potential risks of cardiac arrest.
As drugs for diabetes and weight loss, such as Ozempic and Wegovy, have surged in popularity, so has the issue of fake versions entering the market.
Neuralink's second brain implant surgery was postponed due to the patient's medical condition, with a replacement candidate expected to undergo the procedure next month.
Prescription drug prices in the US have reportedly climbed over the past decade, with a rate far surpassing inflation.
The US Food and Drug Administration (FDA) urged drugmakers and medical device manufacturers to improve racial and cultural diversity in clinical trials.
Holoconnects, a hologram tech firm headquartered in the Netherlands, provided Crescent Regional Hospital in Texas with a state-of-the-art 3D technology called "Holobox."
Two New York pharmacy owners have been sentenced for orchestrating a money laundering scheme involving fraudulent Medicare filings.
